167 related articles for article (PubMed ID: 37936565)
1. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract][Full Text] [Related]
2. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
[TBL] [Abstract][Full Text] [Related]
3. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
4. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L
Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270
[No Abstract] [Full Text] [Related]
5. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; LaƩ M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
Martignoni G; Gobbo S; Camparo P; Brunelli M; Munari E; Segala D; Pea M; Bonetti F; Illei PB; Netto GJ; Ladanyi M; Chilosi M; Argani P
Mod Pathol; 2011 Oct; 24(10):1313-9. PubMed ID: 21602817
[TBL] [Abstract][Full Text] [Related]
8. Is immunohistochemistry always the panacea to morphologic mimics? Two, distinct soft tissue tumors exhibiting alveolar pattern and TFE3 immunoreactivity.
Shah A; Rekhi B; Patil A
Indian J Pathol Microbiol; 2021; 64(4):767-770. PubMed ID: 34673600
[TBL] [Abstract][Full Text] [Related]
9. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
10. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
11. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
12. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
13. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
[TBL] [Abstract][Full Text] [Related]
14. A distinctive subset of PEComas harbors TFE3 gene fusions.
Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
[TBL] [Abstract][Full Text] [Related]
15. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.
Saluja K; Thomas J; Zhang S; Sturgis EM; Jain KS; Prieto VG; El-Naggar AK; Bell D
Hum Pathol; 2018 Jun; 76():149-155. PubMed ID: 29208563
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
[TBL] [Abstract][Full Text] [Related]
17. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of perivascular epithelioid cell neoplasms].
Xia QY; Rao Q; Shen Q; Liu B; Li L; Shi QL; Shi SS; Yu B; Zhang RS; Ma HH; Lu ZF; Wang X; Tu P; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):381-5. PubMed ID: 24060071
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases.
Llamas-Velasco M; Mentzel T; Requena L; Palmedo G; Kasten R; Kutzner H
Histopathology; 2013 Jul; 63(1):122-9. PubMed ID: 23711163
[TBL] [Abstract][Full Text] [Related]
20. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]